The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 07, 2017
Filed:
Mar. 11, 2016
Applicant:
Children's Hospital Medical Center, Cincinnati, OH (US);
Inventors:
Assignee:
Children's Hospital Medical Center, Cincinnati, OH (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); A61K 31/57 (2006.01); C07J 41/00 (2006.01); C07J 7/00 (2006.01); C07J 9/00 (2006.01); C07J 3/00 (2006.01); A61K 31/568 (2006.01); A61K 31/575 (2006.01);
U.S. Cl.
CPC ...
A61K 31/57 (2013.01); A61K 31/56 (2013.01); A61K 31/568 (2013.01); A61K 31/575 (2013.01); C07J 3/00 (2013.01); C07J 7/002 (2013.01); C07J 7/0005 (2013.01); C07J 9/00 (2013.01); C07J 9/005 (2013.01); C07J 41/0005 (2013.01); C07J 41/0016 (2013.01);
Abstract
A composition for use in inhibiting the binding of a Norovirus to the histo-blood group antigen on the surface of epithelia is disclosed. The composition may contain a therapeutically effective amount of a binding-inhibiting compound and a carrier and/or excipient. The compounds may competitively bind a Norovirus that has the capability of binding with the histo-blood group antigens of secretor blood type, including A, B, AB, and O blood types. The compositions may be administered to a human prior to or after infection by a Norovirus, to prevent, ameliorate, or reduce the effects of an infection.